Skip to main content
. 2006 Apr 27;65(11):1473–1477. doi: 10.1136/ard.2005.050443

graphic file with name ar50443.f1.jpg

Figure 1 (A–C) Mean lipid levels and disease activity variables during the 24 weeks of placebo treatment or lefunomide treatment. Antherogenic index, TC/HDLc; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; BASG, Bath Ankylosing Spondylitis Global; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; HDLc, high‐density lipoprotein cholesterol; TC, total cholesterol.